TREM2 has an effect on increasing myeloid cell number in response to inflammation or disease; therefore, TREM2 deficiency is associated to a decrease of activated myeloid cells clustering in AD and to neurodegenerative diseases [106]. This evidence concerns the gene TREM2 and Alzheimer disease.